Document is current

Article History

Received: 29 June 2018

Revised: 15 March 2019

Accepted: 2 May 2019

First Online: 11 June 2019

Competing interests

: All authors who attended the face-to-face meeting, with the exception of T. McCormack, received an honorarium and travel expenses from Roche Products Limited for their participation in the meeting. C.P. has received honoraria for speaking at educational meetings from Amgen, Novartis, Pfizer and Roche. A.O. is an employee of Roche Products Limited. T. McCormack received travel expenses to attend the meeting, but the honorarium offered by Roche was paid into the Whitby Group Practice research fund. T. McCormack is a member of the current NICE Hypertension Guidelines Committee. Remaining authors declare no other conflicts of interest.

: Not applicable.

: This work was supported by Roche Products Limited (Welwyn Garden City, UK). The authors did not receive any compensation for the writing of the paper.

: Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.